We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Adicet Wins FDA Investigational Drug Clearance for NonHodgkin’s Lymphoma Cell Therapy
Adicet Wins FDA Investigational Drug Clearance for NonHodgkin’s Lymphoma Cell Therapy
Adicet has won Investigational New Drug clearance from the FDA for ADI-001, a chimeric antigen receptor (CAR) gamma delta T-cell therapy for nonHodgkin’s lymphoma.